Results per Page:
Multi-omics data unlock TP53 and PTEN gene signatures
From the Paulovich Lab, Translational Science and Therapeutics Division
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
Multiplex quantification of immunomodulatory proteins for cancer diagnostics
From the Paulovich Lab, Translational Science and Therapeutics Division
Localized delivery of CAR T cells to treat children with brain tumors
From the Paulovich Lab, Translational Science and Therapeutics Division and Nicholas Vitanza Seattle Children’s Research Institute
Methods for the masses: multiplexed growth signaling analyses by mass spec
From the Paulovich Lab, Clinical Research Division, and colleagues
Omics made easier
To see the big picture, just add ‘ome’
One more hat: new roles for TGFβ in the DNA damage response
From the Paulovich Lab, Clinical Research Division, and colleagues
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
Targeting metastatic breast cancer with CAR T-cell immunotherapy
$4M 'Breakthrough' award funds collaborative research aimed at destroying dormant disseminated tumor cells
Stronger and faster is not always better
From the Riddell, Paulovich Labs, Clinical Research Division and Gottardo Lab, Vaccine and Infectious Disease Division.
Squelching ovarian cancer: the not-so-silent killer
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
A Science Signaling paper reports how two common CAR designs impact T-cell efficacy against cancer in the laboratory
Want to make better T-cell therapies? First, figure out how they work.
New study maps out activities, effects of widely used components in cellular immunotherapies
Good News: Fred Hutch scientists to develop bioassay for ovarian cancer for new NCI initiative
Celebrating faculty and staff achievements
Proteowhatnow? 6 questions with a proteomics expert
How a new technology could help identify the best cancer treatment for an individual patient
Good News: Communications & Marketing wins 12 creativity awards
Celebrating faculty and staff achievements
Good News: Dr. Jeff Whiteaker wins NCI Research Specialist Award; Human Biology gains four new faculty members
Celebrating faculty and staff achievements